Apr 11, 2026 · 24m · tbpn
Chad Janis: How I Sold Grüns to Unilever for $1.2B
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this in-depth interview, Grüns founder Chad Janis breaks down the meteoric rise of his comprehensive gummy nutrition brand from a Stanford MBA concept to a $1.2 billion acquisition by Unilever. He reveals key strategies behind product innovation, supply chain management, autonomous company culture, and omnichannel retail expansion.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →
The hosts as informed peer 4.5 Guest teaching 3.8 Guest disagreement 0.8 The hosts pushing back 0.5
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 3:24 Chad Janis rejects Goli comparison
Janis explicitly pushes back on the host's attempt to draw a parallel to Goli, explaining that single-ingredient fads fail whereas robust blended formulations endure.
Hardest push from the hosts ▶ 18:28 Host challenges revenue concentration and power law dynamicsThe host presses Janis on whether non-core product lines are actually meaningful or if the business is entirely driven by a single core product power law.
Biggest teaching moment ▶ 3:24 Chad Janis outlines the three eras of gummy supplementsJanis educates the host on the historical evolution of the gummy market from early non-existence to Olly's 2014 entry and current V3 multi-ingredient blends.
The host holds their own ▶ 9:02 Host demonstrates technical knowledge of automated pouch machineryThe host correctly identifies the mechanical bottleneck of sticky gummy formulation jamming standard pouch packing lines compared to in-house industrial lines like General Mills.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Genesis of Grüns and Stanford MBA Epiphany | 5 | 2 | 0 | 0 | The host opens with solid DTC macro context regarding the market trough and past brand struggles. Janis collaboratively walks through his realization drinking green powder before starting his Stanford MBA. | |
| Redefining the Gummy Category Beyond Single Ingredients | 4 | 6 | 2 | 1 | The host questions the gummy form factor citing Goli's decline. Janis corrects the framing by laying out the three generational eras of gummy supplements and distinguishing single-ingredient fads from comprehensive blends. | |
| Overcoming Manufacturing Hurdles and Packaging Automation | 5 | 5 | 1 | 1 | Janis reveals the manual labor required to pack gummies early on, while the host displays industry knowledge about packaging machinery constraints with sticky gummies. | |
| Capital Raising and Omnichannel Acquisition Strategy | 5 | 3 | 1 | 1 | The host probes the paid acquisition mix and inventory risks. Janis explains why they cut marketing spend by 93% overnight to prevent subscriber stockouts. | |
| Consumer Sentiment and Lifestyle Brand Strategy | 4 | 3 | 0 | 0 | Janis explains positioning Grüns as a lifestyle brand modeled after Dr. Squatch rather than solely leaning on clinical trial marketing. | |
| Retail Expansion and Rapid Packaging Redesign | 4 | 3 | 0 | 0 | Janis details the retail rollout timeline across Sprouts, Target, and Walmart, noting how their rapid Canva redesign was necessary for retail shelf readability. | |
| Expanding Product Lines and the Unilever Acquisition | 5 | 4 | 1 | 1 | The host presses on whether revenue follows a power law across SKUs. Janis defends product expansion and explains why Unilever's track record with Liquid I.V. and Nutrafol made them the ideal buyer. | |
| Internal AI Workflow Adoption vs. Human Creative Production | 4 | 4 | 1 | 0 | Janis distinguishes internal AI productivity workflows on Claude from creative ad generation, which remains overwhelmingly human-driven. |
Statements from this episode (16)
Janis: One-quarter of Stanford MBA class tested early Grüns iterations
“About one-fourth of my entire Stanford class tried the early iterations of Grins before we launched.”
Janis: Supplement market enters 'V-three' era of comprehensive gummy blends
“And then I would say we're entering what I would consider a V-three of the Gummy era, which is taking really robust blends and putting them into a form factor like Gummy.”
Janis says Goli struggled by relying on trend-dependent single ingredients
“Goalie, I think they were more focused on individual ingredients that sort of rose and roads that rode with trends and then came back down as that sort of trended away.”
Janis: 19 of 20 co-manufacturers rejected Grüns before its launch
“Early days of the business, pre-launch, the process was calling up 20 different co-bands, co-manufacturing partners, and telling them, here's what I want to do, here's what the ingredients are, I'll source all of it, and every single one of them, except for on…”
Grüns team hand-packed gummies with clamp sealers for first eight months
“That infrastructure for taking gummies and putting it into packs did not exist prior to us. So for the first six to eight months of this business, we had 20 bodies standing around a table. Manually picking up gummies and putting them in packs and taking a clam…”
Janis: Grüns built capacity to ship 10M gummies daily
“Where we can, you know, ship ten million gummies a day and have the infrastructure for it.”
Janis: Grüns Raised Around $50M in Total Capital
“We raised probably around fifty million over the course of the business. Some of that was secondary over the course, then on primary as well, obviously.”
Grüns cut marketing spend by 93% overnight due to inventory shortage
“Six months into the business, January 29th was calling my co-man. I was like, hey, we don't have, it was like two weeks of telling him, hey, I don't think we have enough inventory, right? He's like, no, no, no, we're good. January 29th, I was like, hey, we're …”
Janis says Grüns downplays clinical studies to position as lifestyle brand
“We do clinical research, but we don't, it's not like the only thing we talk about, right? We do we have like studies, we've done all this wonderful stuff, but we try not to lean too much on that because that's what the rest of the category is doing. We're kind…”
Janis: Brands should not have pride in remaining solely direct-to-consumer
“I don't think there's any reason to like, Have pride in being a solely DTC business or a solely on, like, there's just, there's consumers everywhere. Like, meet them with the solution that, and at the price point that works for them.”
Grüns launched in Sprouts, Target, and Walmart between 2024 and 2025
“We launched with Sprouts in October of twenty-twenty-four Target in February of twenty-twenty-five, and then Walmart in April of twenty-twenty-five, and then a bunch of other amazing retailers after that.”
Janis says Unilever publicly stated Liquid I.V. reached $1B in revenue
“They acquired liquid IV back in probably. That business is massively larger. I think they just stated last year that it's around a billion of revenue.”
Grüns connects its data warehouse to Anthropic's Claude for all teams
“We have like all the data infrastructure data warehouse in a place where it's accessible through Claude to our team. So you've got the CX team, you've got the finance team, you've got the marketing team, all like immediately accessible with that information to…”
Janis: Over 99% of Grüns marketing creative remains human-generated
“I would say at this point, we're still like 99% plus like human generated Whether it's like in a editing file or whether it's actual humans creating UGC or working with influencers who are creating content. We haven't moved, I would say into like AI being the …”